BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 8:54:00 PM | Browse: 881 | Download: 736
Publication Name World Journal of Gastroenterology
Manuscript ID 2979
Country South Korea
Received
2013-03-29 12:35
Peer-Review Started
2013-03-29 15:23
To Make the First Decision
2013-04-16 09:17
Return for Revision
2013-04-18 19:37
Revised
2013-05-15 11:13
Second Decision
2013-06-08 14:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-06-10 04:13
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-07-24 15:12
Publish the Manuscript Online
2013-08-06 09:19
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis
Manuscript Source Invited Manuscript
All Author List Do Seon Song, Si Hyun Bae, Myeong Jun Song, Sung Won Lee, Hee Yeon Kim, Young Joon Lee, Jung Suk Oh, Ho Jong Chun, Hae Giu Lee, Jong Young Choi and Seung Kew Yoon
Funding Agency and Grant Number
Funding Agency Grant Number
National R and D Program Grant for Cancer Control from the Ministry of Health, Welfare and Family Affairs, Republic of Korea R0620390-1
Corresponding Author Si Hyun Bae, MD, PhD, Professor, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, #505 Banpo-dong, Seocho-gu, Seoul 137-040, South Korea. baesh@catholic.ac.kr
Key Words Hepatocellular carcinoma; Hepatic arterial infusion chemotherapy; Portal vein tumor thrombosis
Core Tip The aim of this study was to investigate the prognostic factors of hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients with portal vein tumor thrombosis. The primary findings of this study were as follows: (1) The median survival and time to progression were 7 and 2 mo, respectively; (2) A tumor volume of < 400 cm3 and protein induced by vitamin K absence or antagonist-Ⅱ were independent pre-treatment prognostic factors; (3) Disease control and ≥ 50% tumor marker reduction were significant prognostic factors after the second cycle of hepatic arterial infusion chemotherapy (HAIC); and (4) Objective tumor response, disease control and portal vein tumor thrombosis response were independent post-treatment prognostic factors at the end of the HAIC.
Publish Date 2013-08-06 09:19
Citation Song DS, Bae SH, Song MJ, Lee SW, Kim HY, Lee YJ, Oh JS, Chun HJ, Lee HG, Choi JY, Yoon SK. Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2013; 19(29): 4679-4688
URL http://www.wjgnet.com/1007-9327/full/v19/i29/4679.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i29.4679
Full Article (PDF) WJG-19-4679.pdf
Manuscript File 2979-Review.doc
Answering Reviewers 2979-Answering reviewers.doc
Copyright License Agreement 2979-Copyright assignment.PDF
Non-Native Speakers of English Editing Certificate 2979-Language certificate.pdf
Peer-review Report 2979-Peer review(s).pdf
Scientific Editor Work List 2979-Scientific editor work list.doc